New Key Statistics Module, Z-Score and F-Score
NAS:SPRO Key Ratios
Market Cap $ M | 75.45 |
Enterprise Value $ M | 8.43 |
P/E(ttm) | 3.26 |
PE Ratio without NRI | 2.75 |
Forward PE Ratio | -- |
Price/Book | 0.69 |
Price/Sales | 0.70 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 96.00 |
EPS (TTM) $ | 0.43 |
Beneish M-Score | 22.69 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.31 |
EV-to-EBITDA | 0.31 |
PEG | -- |
Shares Outstanding M | 53.89 |
Net Margin (%) | 23.58 |
Operating Margin % | 27.69 |
Pre-tax Margin (%) | 26.26 |
Quick Ratio | 3.53 |
Current Ratio | 3.53 |
ROA % (ttm) | 18.22 |
ROE % (ttm) | 32.02 |
ROIC % (ttm) | 64.34 |
Dividend Yield % | -- |
Altman Z-Score | -0.76 |
Piotroski F-Score | 4.00 |
Positive ROA | Y |
Positive CFROA | N |
Higher ROA y-y | Y |
Cash flow > Earnings | N |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | Y |
SPRO Number of Guru Trades
SPRO Volume of Guru Trades
Gurus Latest Trades with NAS:SPRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SPRO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Spero Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SPRO
Total 0- 1